TickerFactsScreenerDevelopers

Emergent BioSolutions Inc. (EBS) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $91.47M2009: $102.92M2010: $169.02M2011: $143.90M2012: $141.67M2013: $179.34M2014: $280.50M2015: $312.80M2016: $271.50M2017: $178.30M2018: $112.20M2019: $167.80M2020: $621.30M2021: $576.10M2022: $642.60M2023: $111.70M2024: $99.50M2025: $205.40M$205.40M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$205.40M+106.4%
2024$99.50M-10.9%
2023$111.70M-82.6%
2022$642.60M+11.5%
2021$576.10M-7.3%
2020$621.30M+270.3%
2019$167.80M+49.6%
2018$112.20M-37.1%
2017$178.30M-34.3%
2016$271.50M-13.2%
2015$312.80M+11.5%
2014$280.50M+56.4%
2013$179.34M+26.6%
2012$141.67M-1.6%
2011$143.90M-14.9%
2010$169.02M+64.2%
2009$102.92M+12.5%
2008$91.47M—